We previously showed that derivatives of the approved drug cyclosporine A (CsA) inhibit the intoxication of cells with C2 toxin and PT and reduce leukocytosis in an in vivo infection model of pertussis [36,41,42]. This evidence concerns the gene C2 and pertussis.